A double-blind randomized, placebo-controlled, single-center study to assess the impact of statins on the autonomic nervous system and cardiac structure/function in non-ischemic heart failure

Trial Profile

A double-blind randomized, placebo-controlled, single-center study to assess the impact of statins on the autonomic nervous system and cardiac structure/function in non-ischemic heart failure

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2015

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Mar 2012 Additional lead trial centre and investigator (Tamara B Horwich) identified as reported by ClinicalTrials.gov.
    • 30 Mar 2012 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top